Your browser doesn't support javascript.
loading
Restoration of Neutralization Activity Against Omicron BA.2 and BA.5 in Older Adults and Individuals With Risk Factors Following the Fourth Dose of Severe Acute Respiratory Syndrome Coronavirus 2 BNT162b2 Vaccine.
Amano, Masayuki; Otsu, Sachiko; Ichikawa, Yasuko; Higashi-Kuwata, Nobuyo; Matsushita, Shuzo; Shimada, Shinya; Mitsuya, Hiroaki.
Afiliación
  • Amano M; Department of Clinical Retrovirology, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan.
  • Otsu S; Department of Clinical Retrovirology, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan.
  • Ichikawa Y; Kumamoto Ganeral Hospital, Japan Community Health Care Organization, Kumamoto, Japan.
  • Higashi-Kuwata N; Department of Refractory Viral Infections, National Center for Global Health and Medicine Research Institute, Tokyo, Japan.
  • Matsushita S; Department of Clinical Retrovirology, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan.
  • Shimada S; Kumamoto Ganeral Hospital, Japan Community Health Care Organization, Kumamoto, Japan.
  • Mitsuya H; Department of Refractory Viral Infections, National Center for Global Health and Medicine Research Institute, Tokyo, Japan.
J Infect Dis ; 227(1): 161-163, 2022 12 28.
Article en En | MEDLINE | ID: mdl-36134611
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: COVID-19 / Vacuna BNT162 Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Aged / Humans Idioma: En Revista: J Infect Dis Año: 2022 Tipo del documento: Article País de afiliación: Japón
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: COVID-19 / Vacuna BNT162 Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Aged / Humans Idioma: En Revista: J Infect Dis Año: 2022 Tipo del documento: Article País de afiliación: Japón